◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › B › BDX

Becton Dickinson and Company (BDX) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-09-13

Becton Dickinson and Company (BDX) operates in the Health Care Equipment industry and is headquartered in Franklin Lakes, United States with about 72,000 employees. Its market capitalization is roughly $49 billion. In the fiscal year ended 2025-09-30, BDX reported $21.8B in revenue and $1.7B in net income.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

Interactive charts & full statements → Open the BDX valuation workbench →

BDX Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Total Revenue	$20.8B	$21.8B	$20.2B	$19.4B	$18.9B	$19.1B	$16.1B	$17.3B	$16.0B	$12.1B	$12.5B	$10.3B	$8.4B	$8.1B	$7.7B	$7.6B	$7.1B	$7.0B	$7.1B	$6.4B	$5.7B
Gross Profit	$9.6B	$9.9B	$9.1B	$8.2B	$8.5B	$8.6B	$6.8B	$8.3B	$7.3B	$6.0B	$6.0B	$4.7B	$4.3B	$4.2B	$4.0B	$4.0B	$3.7B	$3.7B	$3.6B	$3.3B	$2.9B
Gross Margin %	46.1%	45.4%	45.2%	42.2%	44.9%	45.1%	42.3%	47.9%	45.5%	49.3%	48.0%	45.7%	50.9%	51.8%	51.3%	52.2%	51.9%	52.6%	51.3%	51.7%	51.3%
Operating Income (EBIT)	$2.0B	$2.6B	$2.4B	$2.1B	$2.3B	$2.2B	$912M	$1.8B	$1.5B	$1.5B	$1.4B	$1.1B	$1.6B	$1.3B	$1.6B	$1.7B	$1.6B	$1.6B	$1.5B	$1.2B	$1.1B
Operating Margin %	9.8%	11.8%	11.9%	10.9%	12.1%	11.8%	5.7%	10.2%	9.4%	12.6%	11.5%	10.4%	19.0%	15.6%	20.2%	22.0%	22.2%	22.8%	21.7%	18.9%	19.9%
Net Income	$941M	$1.7B	$1.7B	$1.5B	$1.8B	$2.1B	$874M	$1.2B	$311M	$1.1B	$976M	$695M	$1.2B	$1.3B	$1.2B	$1.3B	$1.3B	$1.2B	$1.1B	$890M	$752M
Net Margin %	4.5%	7.7%	8.5%	7.7%	9.4%	10.9%	5.4%	7.1%	1.9%	9.1%	7.8%	6.8%	14.0%	16.1%	15.2%	16.8%	18.5%	17.6%	15.9%	14.0%	13.1%
EBITDA	$3.9B	$5.0B	$4.8B	$4.4B	$4.4B	$4.4B	$3.1B	$4.1B	$3.9B	$2.6B	$2.6B	$2.0B	$2.2B	$1.8B	$2.1B	$2.2B	$2.1B	$2.1B	$2.1B	$1.8B	$1.6B
Earnings Per Share (EPS)	$3.32	$5.84	$5.86	$5.15	$6.19	$7.16	$3.09	$4.49	$1.18	$4.92	$4.49	$3.35	$5.99	$6.49	$5.59	$5.62	$5.49	$4.99	$4.46	$3.49	$2.93
Shares Outstanding (M)	275M	287M	291M	288M	287M	292M	282M	275M	265M	224M	218M	208M	198M	199M	209M	226M	240M	247M	253M	255M	257M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BDX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$5.0B	$4.7B	$5.3B	$5.9B	$5.5B	$5.3B	$5.2B	$5.4B
Gross Profit	$2.3B	$2.2B	$2.3B	$2.8B	$2.6B	$2.3B	$2.2B	$2.5B
Gross Margin %	46.5%	45.7%	44.6%	47.5%	47.8%	42.8%	43.2%	45.7%
Operating Income (EBIT)	$663M	$94M	$594M	$697M	$882M	$546M	$453M	$622M
Operating Margin %	13.3%	2.0%	11.3%	11.8%	16.0%	10.4%	8.8%	11.4%
Net Income	$377M	($311M)	$382M	$493M	$574M	$308M	$303M	$400M
Net Margin %	7.6%	-6.6%	7.3%	8.4%	10.4%	5.8%	5.9%	7.4%
EBITDA	$686M	$709M	$1.2B	$1.3B	$1.5B	$1.1B	$1.1B	$1.3B
Earnings Per Share (EPS)	$1.37	$-1.11	$1.34	$1.72	$1.99	$1.07	$1.04	$1.38
Shares Outstanding (M)	275M	281M	285M	287M	289M	289M	290M	291M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BDX Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Cash from Operations (CFO)	$3.3B	$3.4B	$3.8B	$3.0B	$2.6B	$4.6B	$3.5B	$3.3B	$2.9B	$2.5B	$2.6B	$1.7B	$1.7B	$1.5B	$1.8B	$1.7B	$1.7B	$1.7B	$1.7B	$1.2B	$1.1B
Capital Expenditures (CapEx)	$728M	$760M	$725M	$874M	$973M	$1.2B	$810M	$957M	$895M	$727M	$718M	$633M	$653M	$588M	$554M	$605M	$632M	$701M	$651M	$579M	$482M
Free Cash Flow (FCF)	$2.6B	$2.7B	$3.1B	$2.1B	$1.7B	$3.4B	$2.7B	$2.4B	$2.0B	$1.8B	$1.8B	$1.1B	$1.1B	$919M	$1.2B	$1.1B	$1.1B	$1.0B	$1.0B	$662M	$594M
FCF Margin %	12.5%	12.2%	15.2%	10.9%	8.8%	17.9%	17.0%	13.7%	12.3%	15.1%	14.8%	10.7%	12.9%	11.4%	15.7%	14.6%	15.6%	14.5%	14.6%	10.4%	10.4%
Dividends Paid	$1.8B	$1.2B	$1.1B	$1.1B	$1.1B	$1.0B	$1.0B	$984M	$927M	$677M	$562M	$485M	$421M	$386M	$368M	$361M	$346M	$317M	$279M	$240M	$212M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BDX Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$652M	$671M	$657M	$1.4B	$1.2B	$164M	$693M	$1.2B
Capital Expenditures (CapEx)	$143M	$125M	$108M	$352M	$174M	$129M	$105M	$296M
Free Cash Flow (FCF)	$509M	$546M	$549M	$1.0B	$1.0B	$35M	$588M	$882M
FCF Margin %	10.2%	11.6%	10.4%	17.0%	19.0%	0.7%	11.4%	16.2%
Dividends Paid	$875M	$290M	$299M	$297M	$299M	$298M	$302M	$275M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BDX Balance Sheet History

Balance sheet	2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Total Assets	$50.7B	$55.3B	$57.3B	$52.8B	$52.9B	$53.9B	$54.0B	$51.8B	$53.9B	$37.7B	$25.6B	$26.8B	$12.4B	$12.1B	$11.4B	$10.4B	$9.7B	$9.3B	$7.9B	$7.3B	$6.8B
Cash & Cash Equivalents	$708M	$851M	$1.9B	$1.4B	$1.2B	$2.4B	$2.8B	$536M	$1.1B	$14.2B	$1.5B	$1.4B	$1.9B	$1.9B	$1.7B	$1.2B	$1.2B	$1.4B	$830M	$511M	$1.0B
Total Liabilities	$26.3B	$29.9B	$31.4B	$27.0B	$27.7B	$30.2B	$30.2B	$30.7B	$32.9B	$24.8B	$18.0B	$19.3B	$7.4B	$7.1B	$7.2B	$5.6B	$4.2B	$4.2B	$3.0B	$3.0B	$3.0B
Total Debt (Short + Long-Term)	$16.8B	$19.2B	$20.3B	$16.0B	$16.2B	$17.7B	$17.9B	$19.4B	$21.5B	$18.9B	$11.6B	$12.8B	$4.0B	$4.0B	$4.2B	$2.7B	$1.7B	$1.9B	$1.2B	$1.2B	$1.4B
Total Shareholders' Equity	$24.4B	$25.4B	$25.9B	$25.8B	$25.3B	$23.7B	$23.8B	$21.1B	$21.0B	$12.9B	$7.6B	$7.2B	$5.1B	$5.0B	$4.1B	$4.8B	$5.4B	$5.1B	$4.9B	$4.4B	$3.8B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BDX viewer.

BDX Metric Deep Dives

Other Companies in Health Care Equipment

MDT · Medtronic — $118 billion
SYK · Stryker Corporation — $106 billion
BSX · Boston Scientific — $63 billion
EW · Edwards Lifesciences — $51 billion
IDXX · Idexx Laboratories — $40 billion
DXCM · Dexcom — $34 billion
RMD · ResMed — $32 billion
GEHC · GE HealthCare — $29 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← BDVL All “B” companies BDYN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.